ArticleCureus2026
Patient-Reported Outcomes After Septoplasty With Bilateral Radiofrequency Inferior Turbinate Reduction: A Prospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNasal septal deviation (NSD) is a common anatomical condition that contributes to nasal obstruction and may significantly impair patients' quality of life. Septoplasty is a standard surgical treatment for symptomatic septal deviation and may be combined with inferior turbinate reduction when turbinate hypertrophy contributes to nasal obstruction. However, postoperative outcomes vary among patients, and the degree of symptom improvement is not always consistent. The aim of this study was to evaluate patient-reported outcomes following septoplasty with bilateral radiofrequency reduction of the inferior turbinates using the Nasal Obstruction Symptom Evaluation (NOSE) scale and the 22-item Sino-Nasal Outcome Test (SNOT-22) and to compare postoperative outcomes with those of healthy controls.
methodsA total of 43 patients with symptomatic nasal septal deviation and nasal obstruction were prospectively enrolled, along with 20 healthy controls. All patients underwent conventional septoplasty with concomitant bilateral radiofrequency reduction of the inferior turbinates. Patients completed the validated Greek versions of the NOSE and SNOT-22 questionnaires before surgery and six months postoperatively. Healthy controls completed both questionnaires at baseline. Baseline demographic characteristics, including age, sex, and body mass index (BMI), were also recorded.
resultsBoth NOSE and SNOT-22 scores improved significantly six months after the combined surgical intervention compared with preoperative values (p < 0.001). The mean improvement in SNOT-22 score was 56.51 ± 12.67 points, while the mean improvement in NOSE score was 57.44 ± 12.55 points. At six months, postoperative NOSE and SNOT-22 scores were not significantly different from those observed in healthy controls. Age and BMI were not significantly associated with preoperative NOSE or SNOT-22 scores, whereas male patients had significantly higher preoperative SNOT-22 scores than female patients.
conclusionsSeptoplasty with bilateral radiofrequency reduction of the inferior turbinates was associated with significant improvement in patient-reported nasal obstruction symptoms and sinonasal quality of life at six months, as reflected by marked reductions in NOSE and SNOT-22 scores. Postoperative questionnaire scores were not significantly different from those of healthy controls. Because both procedures were performed concomitantly in all patients, the relative contribution of septoplasty and inferior turbinate reduction to the observed improvement cannot be determined separately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.